{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:09:24Z","timestamp":1789823364268,"version":"4.0.1"},"reference-count":20,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biol Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1134\/s0012496624701035","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:01:45Z","timestamp":1719932505000},"page":"55-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Effect of Basic Antiherpetic Drugs with a New Inhibitor of the Terminase Complex of Herpes Simplex Virus Type 1 in Vero Cell Cultures"],"prefix":"10.1134","volume":"517","author":[{"given":"V. L.","family":"Andronova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Galegov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Vozdvizhenskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Levit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. N.","family":"Charushin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"8365_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2471\/BLT.19.237149","volume":"98","author":"C. James","year":"2020","unstructured":"James, C., Harfouche, M.,Turner, K.M., et al., Herpes simplex virus: Global infection prevalence and incidence estimates, 2016, Bull. W. H. O., 2020, vol. 98, no.\u00a05, pp. 315\u2013329.","journal-title":"Bull. W. H. O."},{"key":"8365_CR2","doi-asserted-by":"crossref","unstructured":"Das, D. and Hong, J., Viral Polymerases: Structures, Functions and Roles As Antiviral Drug Targets, Ch. 12: Herpesvirus polymerase inhibitors, Gupta, S.P., Ed., London: Academic Press, 2019, pp. 333\u2013356.","DOI":"10.1016\/B978-0-12-815422-9.00012-7"},{"key":"8365_CR3","unstructured":"Garikapati, S. and Nguyen, M., Foscarnet, Treasure Island: StatPearls, 2023."},{"key":"8365_CR4","unstructured":"Drug Monograph Cidofovir. Elsevier: Content from Elsevier\u2019s drug information, 2023. https:\/\/elsevier.health\/en-US\/preview\/cidofovir. Cited August 10, 2023."},{"key":"8365_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.18821\/0507-4088-2018-63-4-149-159","volume":"63","author":"V.L. Andronova","year":"2018","unstructured":"Andronova, V.L., Modern ethiotropic chemotherapy of Herpesvirus infections: advances, new trends and perspectives. Alphaherpesviruses (Part II), Vopr. Virusol., 2018, vol. 63, no. 4, pp. 149\u2013159. https:\/\/doi.org\/10.18821\/0507-4088-2018-63-4-149-159","journal-title":"Vopr. Virusol."},{"key":"8365_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2016.01.013","volume":"18","author":"A. Birkmann","year":"2016","unstructured":"Birkmann, A. and Zimmermann, H., HSV antivirals\u2014 current and future treatment options, Curr. Opin. Virol., 2016, vol. 18, pp. 9\u201313.","journal-title":"Curr. Opin. Virol"},{"key":"8365_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","volume":"43","author":"L. Men\u00e9ndez-Arias","year":"2022","unstructured":"Men\u00e9ndez-Arias, L. and Delgado, R., Update and latest advances in\u00a0antiretroviral\u00a0therapy, Trends Pharmacol. Sci., 2022, vol. 43, no. 1, pp. 16\u201329.","journal-title":"Trends Pharmacol. Sci"},{"key":"8365_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","volume":"64","author":"C. Sarrazin","year":"2016","unstructured":"Sarrazin, C., The importance of resistance to direct antiviral drugs in HCV infection in clinical practice, J.\u00a0Hepatol., 2016, vol. 64, no. 2, pp. 486\u2013504.","journal-title":"J.\u00a0Hepatol"},{"key":"8365_CR9","doi-asserted-by":"publisher","first-page":"105499","DOI":"10.1016\/j.antiviral.2022.105499","volume":"210","author":"J.C. Jones","year":"2023","unstructured":"Jones, J.C., Yen, H.-L., Adams, P., et al., Influenza antivirals and their role in pandemic preparedness, Antiviral Res., 2023, vol. 210, p. 105499.","journal-title":"Antiviral Res"},{"key":"8365_CR10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S1473-3099(17)30476-0","volume":"17","author":"J.H. Beigel","year":"2017","unstructured":"Beigel, J.H., Bao, Y., Beeler, J., et al., Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: A multicentre, double-blind, randomised phase 2 trial, Lancet Infect. Dis., 2017, vol. 17, no. 12, pp. 1255\u20131265.","journal-title":"Lancet Infect. Dis"},{"key":"8365_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neurol.2017.03.006","volume":"173","author":"S. Sagnier","year":"2017","unstructured":"Sagnier, S., Poli, M., Debruxelles, S., et al., High-dose acyclovir combined with foscavir (foscarnet) in the management of severe Herpes simplex virus meningoencephalitis, Revue Neurologique, 2017, vol. 173, no. 4, pp. 240\u2013242.","journal-title":"Revue Neurologique"},{"key":"8365_CR12","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1002\/ejoc.201900727","volume":"2019","author":"V.P. Krasnov","year":"2019","unstructured":"Krasnov, V.P., Musiyak, V.V., Vozdvizhenskaya, O.A., et al., N-[\u03c9-(Purin-6-yl)aminoalkanoyl] derivatives of chiral heterocyclic amines as promising anti-herpesvirus agents, Eur. J. Org. Chem., 2019, vol. 2019, no. 30, pp. 4811\u20134821.","journal-title":"Eur. J. Org. Chem"},{"key":"8365_CR13","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.3390\/molecules28217375","volume":"28","author":"V.P. Krasnov","year":"2023","unstructured":"Krasnov, V.P., Andronova, V.L., Belyavsky, A.V., et al., Large subunit of the human Herpes simplex virus terminase as a promising target in design of anti-herpesvirus agents, Molecules, 2023, vol. 28, no. 21, p. 7375.","journal-title":"Molecules"},{"key":"8365_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13238-020-00710-0","volume":"11","author":"Y. Yang","year":"2020","unstructured":"Yang, Y., Yang, P., Wang, N., et al., Architecture of the herpesvirus genome-packaging complex and implications for DNA translocation, Protein Cell, 2020, vol. 11, no. 5, pp. 339\u2013351.","journal-title":"Protein Cell"},{"key":"8365_CR15","unstructured":"Previmis (Previmis). Vidal drug information systems. https:\/\/www.vidal.ru\/drugs\/previmis. Cited December 18, 2023."},{"key":"8365_CR16","unstructured":"Maruho receives manufacturing and marketing approval for a partial change of the indication and dosage\/administration for anti-herpes virus agent \u201cAmenalief Tab. 200mg\u201d for the treatment of recurrent Herpes simplex in Japan. NewsRelease 2023.02.24. \nhttps:\/\/www.maruho.co.jp\/english\/information\/20230224.html. Cited February 24, 2023."},{"key":"8365_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/v13081547","volume":"13","author":"K. Shiraki","year":"2021","unstructured":"Shiraki, K., Yasumoto, S., Toyama, N., et al., Amenamevir, a helicase-primase inhibitor, for the optimal treatment of herpes zoster, Viruses, 2021, vol. 13, no. 8, p. 1547.","journal-title":"Viruses"},{"key":"8365_CR18","first-page":"32","volume":"59","author":"V.L. Andronova","year":"2014","unstructured":"Andronova, V.L., Jasko, M.V., Kukhanova, M.K., et\u00a0al., Research of suppression of the Herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs, Probl. Virol., 2014, vol. 59, no. 6, pp. 32\u201335.","journal-title":"Probl. Virol."},{"key":"8365_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","volume":"40","author":"C.L. Poole","year":"2018","unstructured":"Poole, C.L. and James, S.H., Antiviral therapies for herpesviruses: Current agents and new directions, Clin. Ther., 2018, vol. 40, no. 8, pp. 1282\u20131298.","journal-title":"Clin. Ther"},{"key":"8365_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2165\/00002018-200528120-00007","volume":"28","author":"E.N. Van Roon","year":"2005","unstructured":"Van Roon, E.N., Flikweert, S., Le Comte, M., et al., Clinical relevance of drug-drug interactions: A structured assessment procedure, Drug Saf. J., 2005, vol. 28, no. 12, pp. 1131\u20131139.","journal-title":"Drug Saf. J."}],"container-title":["Doklady Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0012496624701035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0012496624701035","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0012496624701035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:36:23Z","timestamp":1773765383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0012496624701035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8365"],"URL":"https:\/\/doi.org\/10.1134\/s0012496624701035","relation":{},"ISSN":["0012-4966","1608-3105"],"issn-type":[{"value":"0012-4966","type":"print"},{"value":"1608-3105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"This work does not contain any studies involving human and animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}}]}}